X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-18 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $7.21 | +138,000 | 13,817,055 | +1% | +$994,980 | ||||||
2022-05-18 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $7.21 | +138,000 | 13,817,055 | +1% | +$994,980 | ||||||
2022-05-16 | EWTX | Moore John R | GC | S - Sale | $7.42 | -10,800 | 3,000 | -78% | -$80,146 | ||||||
2021-11-15 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $19.11 | -479 | 0 | -100% | -$9,155 | ||||||
| M | 2021-11-09 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $19.91 | -69,740 | 479 | -99% | -$1,388,788 | |||||
| M | 2021-11-04 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $19.82 | -29,451 | 70,219 | -30% | -$583,823 | |||||
| M | 2021-11-01 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $17.88 | -44,172 | 99,670 | -31% | -$789,909 | |||||
| M | 2021-10-14 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $18.17 | -7,182 | 143,842 | -5% | -$130,483 | |||||
2021-10-11 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $18.02 | -1,270 | 151,024 | -1% | -$22,885 | ||||||
| M | 2021-10-06 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $18.39 | -21,028 | 152,294 | -12% | -$386,743 | |||||
| M | 2021-10-01 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $18.24 | -5,778 | 173,322 | -3% | -$105,409 | |||||
| M | 2021-09-28 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $17.10 | -26,454 | 179,100 | -13% | -$452,483 | |||||
| M | 2021-09-23 | EWTX | Russell Alan J | Chief Scientific Officer | S - Sale | $18.30 | -58,546 | 205,554 | -22% | -$1,071,422 | |||||
| D | 2021-03-30 | EWTX | Root Jonathan D | Dir | P - Purchase | $16.00 | +15,625 | 3,489,168 | 0% | +$250,000 | |||||
| D | 2021-03-30 | EWTX | Thompson Peter A. | Dir, 10% | P - Purchase | $16.00 | +359,375 | 13,359,456 | +3% | +$5,750,000 | |||||
| D | 2021-03-30 | EWTX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $16.00 | +359,375 | 13,359,456 | +3% | +$5,750,000 | |||||
| D | 2021-03-30 | EWTX | Novo Holdings A/s | 10% | P - Purchase | $16.00 | +625,000 | 5,587,207 | +13% | +$10,000,000 | |||||
| D | 2021-03-30 | EWTX | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $16.00 | +625,000 | 3,933,137 | +19% | +$10,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |